ALBUTEIN 5% SOLN USP 50 MG — DIN 00779563
ALBUMIN : 50 MG · GRIFOLS BIOLOGICALS LLC · SOLUTION · wholesale supply in Canada
Health Canada status: DORMANT
What is ALBUTEIN 5% SOLN USP?
ALBUTEIN 5% SOLN USP 50 MG contains ALBUMIN : 50 MG. It is listed in the Health Canada Drug Product Database under DIN 00779563, held by GRIFOLS BIOLOGICALS LLC, supplied as SOLUTION for INTRAVENOUS administration. Health Canada currently lists it as dormant, status dated 03-Aug-2017. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A). This DIN is not currently being marketed in Canada, so it is sourced to order where a compliant route exists rather than held in stock.
How much does Albumin cost around the world?
Albumin is listed on 6 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Bahrain publishes a retail (max); Czechia publishes a max producer price (ex-factory); Greece publishes a producer price (ex-factory). Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| Czechia | max producer price (ex-factory) | 6 | 17 | CZK███.██ |
| Norway | max AUP (pharmacy retail) | 5 | 16 | NOK███.██ |
| Greece | producer price (ex-factory) | 13 | 13 | EUR███.██ |
| Iceland | max wholesale | 5 | 10 | ISK███.██ |
| Bahrain | retail (max) | 1 | 2 | BHD███.██ |
| Hungary | producer price (ex-factory) | 1 | 2 | HUF███.██ |
60 pack listings across 31 brand entries and 5 price bases, refreshed 07 Sep 2026. Ranges span every Albumin pack in that market, so a high figure is usually a larger pack rather than the same product.
Canada publishes no comparable public list price. For a delivered Canadian price on a licensed account, verify your licence — it takes about a minute.
Is there a generic Albumin in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
10 holders have a Canadian DIN containing Albumin, across 20 DINs, of which 5 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| GRIFOLS THERAPEUTICS LLC | 4 | 3 | ALBUMIN (HUMAN) 25% SOLUTION USP, ALBUMIN (HUMAN) 5% SOLUTION, USP, PLASBUMIN-25, PLASBUMIN-5 | Sourceable in Canada |
| CSL BEHRING CANADA INC | 2 | 2 | ALBUREX - 25, ALBUREX - 5 | Sourceable in Canada |
| CUTTER MED & BIOL, DIVISION OF MILES CANADA LTD. | 3 | 0 | NORMAL SERUM ALBUMIN HUMAN 25% USP, PLASBUMIN-5 INJ 50MG/ML, PLASMANATE INJ 0.05GM/ML USP | No marketed DIN |
| BAXTER AG | 2 | 0 | ALBUMIN (HUMAN) 25% SOLUTION, ALBUMIN (HUMAN) 5% SOLUTION | No marketed DIN |
| BAXTER HEALTHCARE CORPORATION | 2 | 0 | BUMINATE 25%, BUMINATE 5% | No marketed DIN |
| GRIFOLS BIOLOGICALS LLC | 2 | 0 | ALBUTEIN 25% SOLN USP, ALBUTEIN 5% SOLN USP | No marketed DIN |
| OCTAPHARMA PHARMAZEUTIKA PRODUKTIONSGES M B H | 2 | 0 | OCTALBIN 25%, OCTALBIN 5% | No marketed DIN |
| BEHRINGWERKE AG | 1 | 0 | HUMANALBIN INJ 5% | No marketed DIN |
| INSTITUTO GRIFOLS S.A. | 1 | 0 | HUMAN ALBUMIN GRIFOLS 20% | No marketed DIN |
| ZLB BEHRING LLC | 1 | 0 | ALBUMINAR-25 | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 50 MG |
|---|---|
| Dosage form | SOLUTION |
| Route | INTRAVENOUS |
Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Substance and classification
| Active substance | Albumin |
|---|---|
| ATC code | B05AA01 |
| AHFS class | 48:08.00 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 00779563 |
|---|---|
| DIN (unpadded, as printed on some documents) | 779563 |
| Brand name | ALBUTEIN 5% SOLN USP |
| Generic / active ingredient | ALBUMIN : 50 MG |
| Market authorization holder | GRIFOLS BIOLOGICALS LLC |
| Health Canada schedule | Schedule D |
| ATC code | B05AA01 |
| ATC anatomical main group | B — Blood and blood-forming organs |
| ATC therapeutic subgroup | B05AA |
| Current status | DORMANT |
| Status date | 03-Aug-2017 |
| Original market date | 1977-12-31 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
5 of 20 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| ALBUMIN (HUMAN) 25% SOLUTION USP | 25 % | SOLUTION | GRIFOLS THERAPEUTICS LLC | MARKETED | 02223708 |
| ALBUMIN (HUMAN) 5% SOLUTION, USP | 5 % | SOLUTION | GRIFOLS THERAPEUTICS LLC | MARKETED | 02223694 |
| ALBUREX - 25 | 25 % | SOLUTION | CSL BEHRING CANADA INC | MARKETED | 02274663 |
| ALBUREX - 5 | 5 % | SOLUTION | CSL BEHRING CANADA INC | MARKETED | 02274655 |
| PLASBUMIN-5 | 50 MG | SOLUTION | GRIFOLS THERAPEUTICS LLC | MARKETED | 02189100 |
| ALBUMIN (HUMAN) 25% SOLUTION | 25 % | SOLUTION | BAXTER AG | CANCELLED POST MARKET | 00427659 |
| ALBUMIN (HUMAN) 5% SOLUTION | 5 % | SOLUTION | BAXTER AG | CANCELLED POST MARKET | 00427675 |
| ALBUMINAR-25 | 25 G / 100 ML | SOLUTION | ZLB BEHRING LLC | CANCELLED POST MARKET | 00624608 |
| ALBUTEIN 25% SOLN USP | 250 MG | SOLUTION | GRIFOLS BIOLOGICALS LLC | DORMANT | 00779571 |
| BUMINATE 25% | 25 % | SOLUTION | BAXTER HEALTHCARE CORPORATION | CANCELLED POST MARKET | 00118303 |
2 · Same class — other molecules in ATC B05AA
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Albumin | ALBUMIN (HUMAN) 25% SOLUTION · ALBUMIN (HUMAN) 25% SOLUTION USP · ALBUMIN (HUMAN) 5% SOLUTION · ALBUMIN (HUMAN) 5% SOLUTION, USP · +16 more | 20 | 5 | Yes |
| Dextran,Combinations | 10% DEXTRAN 40 IN 0.9% SODIUM CHLORIDE INJECTION · 10% DEXTRAN 40 IN 5% DEXTROSE INJECTION · 6% DEXTRAN 70 IN 0.9% SODIUM CHLORIDE INJECTION · DEXTRAN 6% IN 0.9% SODIUM CHLORIDE INJECTION · +10 more | 14 | 2 | Yes |
| Hydroxyethylstarch | HEXTEND · PENTASPAN · VOLULYTE · VOLUVEN | 4 | 2 | Yes |
| Other Plasma Protein Fractions | PLAS+SD · PLASMA PROTEIN FRACTION (HUMAN) PROTENATE | 2 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC B05A
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| B05AX | Blood Plasma | 1 | 1 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is ALBUTEIN 5% SOLN USP called?
The same molecule, Albumin, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Alburex | Latin | Czechia, Iceland, Norway |
| ALBUTEIN | Latin | Czechia, Iceland |
| Albunorm | Latin | Czechia, Norway |
| Albumin Grifols | Latin | Norway |
| Flexbumin | Latin | Czechia, Iceland, Norway |
| Albumin Baxalta | Latin | Iceland, Norway |
| HUMAN ALBUMIN BAXALTA | Latin | Czechia |
| HUMAN ALBUMIN CSL BEHRING | Latin | Czechia |
| HUMAN ALBUMIN OCTAPHARMA | Latin | Bahrain |
| Albuman | Latin | Iceland |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
How can I get it?
This DIN is dormant — it holds a Health Canada authorization but is not currently being marketed in Canada, so it cannot simply be ordered from Canadian stock. Where a patient need exists, supply may be possible through exceptional importation or the Special Access Programme, subject to Health Canada's requirements and the prescriber's application. Nexara can advise on the route and on marketed alternatives.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.